n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, September 19th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Zadar Ventures Ltd. (ZADDF)

OTC Markets, InvestorsHub, and Barchart reported on Zadar Ventures Ltd. (ZADDF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

A Resource Company, Zadar Ventures Ltd. concentrates on the acquisition and exploration of economically viable green energy resources in jurisdictions favorable to mining and industry. Headquartered in Vancouver, British Columbia, the Company has its WSP claims and CR claims in Clayton Valley, Nevada. Listed on the OTCQB, Zadar Ventures explores for lithium and uranium deposits. 

The Company has a 100 percent ownership option on the WSP claims. This asset is 425 hectares of ground permissive to host brines containing elevated concentrations of lithium. The WSP claims are situated immediately adjacent to the Li Producing Albemarle Silver Peak Mine Complex.

In addition, Zadar has a 100 percent ownership option on the CR claims. This asset contains more than 330 hectares of an isolated and un-drilled basin target. This target has the potential to host (if a closed basin) an alike lithium brine environment to the Clayton Valley brines. The CR claims are situated 18 km SE of the Rockwood Lithium Production Complex.

This past April, Zadar Ventures announced that it entered into a Memorandum of Understanding (MOU) with FlowBack Solutionz Canada, Inc. to test FlowBack's unique and proprietary waste water treatment technology for lithium extraction from Petrobrines from the Company's Manitoba Petrobrine projects. FlowBack is a Canadian oil well waste water treatment enterprise.

Today, Zadar Ventures reported that a detailed CSAMT/MT (StrataGem) survey was completed over the WSP Lithium Brine Project. The design of the survey was to complement the July 2016 Gravity survey and historic, more widely spaced gravity surveys and available drill data, which had identified a discreet, northeast trending gravity low on the WSP Project. Management interprets this to represent a basinal structure capable of hosting brines with elevated lithium.

Preliminary inspection of the data during the field survey has indicated a conductive zone at depth. This may represent the newly discovered gravel zone drilled by Lithium X Energy Corp. that was reported to be 100 meters in thinness. This gravel zone only occurs in the northern part of Clayton Valley. In addition, Zadar Ventures has renewed all of its Clayton Valley land holdings with the BLM (Bureau of Land Management) and is in good standing.

Zadar Ventures Ltd. (ZADDF), closed Tuesday's trading session at $0.0813, up 62.60%, on 2,100 volume with 2 trades. The average volume for the last 60 days is 27,540 and the stock's 52-week low/high is $0.05/$0.1224.

Barfresh Food Group, Inc. (BRFH)

Greenbackers, OTCJournal, RedChip, Lions of Wall Street, Barchart, Marketbeat, The Wall Street Transcript, SmallCap Network, Wall Street Resources, and SmallCapVoice reported on Barfresh Food Group, Inc. (BRFH), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Barfresh Food Group, Inc. is a manufacturer and distributor of unique, frozen, ready-to-blend beverages. These include smoothies, shakes, and fr appes. These products are primarily for restaurant chains and the foodservice industry. Barfresh Food Group and Barfresh Food Group Pty Ltd. in Australia (Barfresh Australia) are under common control. Barfresh Food Group has its corporate office in Beverly Hills, California.

Barfresh acquired the exclusive global patent rights to its ready-to-blend beverage packs. This is on top of its currently held patent rights in the United States and Canada. With this acquisition, the Company gains exclusive rights to service important international markets. These include, but are not limited to China, Europe, Japan, Brazil, and Australia and New Zealand. The rights acquired by Barfresh include all international patents and trademarks covered under the international Patent Cooperation Treaty. 

Barfresh has acquired the intellectual property (IP) for its creative “ready to blend” ingredient packs for North America. The Company’s proprietary, patented system uses portion-controlled pre-packaged beverage ingredients. These deliver freshly made smoothies that are fast, cost efficient, and without waste. 

The innovative system combines all the ingredients of a quality smoothie into an individually pre-portioned pack. The pack contains real fruit pieces, low fat frozen yogurt or sorbet, fruit juice, and the ice. This is subsequently blended with water to create a smoothie. 
  
Barfresh Food Group announced in May of this year that it is expanding its distribution footprint into eastern Canada. This is following an agreement with one of Canada's top foodservice brokers based in Toronto, Ontario.

Regarding Barfresh Food Group’s Education Channel expansion,  it recently announced the introduction of a new range of smoothies in response to customer demand, which fulfills the requirements set forth by the USDA within its national school meal programs that provide the mechanism through which schools can be reimbursed for daily meals.

Barfresh is addressing this market with a product that contains a minimum of a half cup of real fruit and four ounces of yogurt for every eight ounce serving. This product has no added sugar and no artificial ingredients or preservatives. Moreover, it meets all the restricted calorie requirements among other criteria.  Barfresh has its first contract in this new business channel, covering 30 Florida schools.

Barfresh Food Group, Inc. (BRFH), closed Tuesday's trading session at $0.58, up 5.45%, on 38,267 volume with 11 trades. The average volume for the last 60 days is 48,875 and the stock's 52-week low/high is $0.52/$0.83.

MariMed, Inc. (MRMD)

OTC Markets reported on MariMed, Inc. (MRMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

MariMed, Inc. is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation and production centers and dispensaries. The Company provides turnkey solutions to cannabis cultivators, producers, and dispensaries. It specializes in solutions for securing and operating facilities, manufacturing and processing, dispensary, layouts, and designs, merchandising and sales.  MariMed is based in Newton, Massachusetts.

Worlds Online (MRMD) formerly (WORX) acquired the remaining 49 percent stake in MariMed Advisors for 75 million shares of common stock (restricted for 12 months), bringing its ownership of the subsidiary to 100 percent. Worlds Online changed its name to MariMed, Inc.

The Company is concentrating exclusively on serving the quick expanding $7 billion legal cannabis industry.  MariMed will spin out Worlds Online’s legacy 3D virtual community business to a newly created subsidiary corporation.

MariMed reported strong revenue growth for 2016 that continued into this year.   MariMed more than doubled revenue in 2016 over 2015, increasing from $1.27 million in 2015 to $3.56 million in 2016. Most of the revenue was attributable to subsidiary MariMed Advisors and its cannabis services and products business.

MariMed is on the leading edge of medical research, working to create precision dosed products to treat specific conditions. Its team has developed state-of-the-art and regulatory compliant facilities in many states. These facilities are replicable and scalable models of excellence in horticultural principals, cannabis production, product development, and dispensary operations.

MariMed’s services include application assistance, real estate and safe access, build-out and ongoing consultation, business acceleration solutions, and physician and patient outreach. MariMed Advisors, Inc. has a portfolio of high-quality branded products, product development plans, product packaging, as well as product licensing opportunities.

MariMed provides a complete range of consulting services in the medical cannabis industry. It uses a systematic approach, from the permit and application process, to on-time operational readiness. As Cannabis experts, it specializes in supporting the development of high quality state-licensed, medical cannabis dispensaries and cultivation facilities.

Today, Tikun Olam, the world pioneer in cannabis research, and MariMed announced an expansion of their licensing agreement for Tikun Olam products to be grown, manufactured, and also sold via MariMed's network of managed and affiliated licensed facilities across the U.S. The new agreement brings Tikun Olam's premium cannabis products, years of proprietary, peer-reviewed scientific research, and unprecedented clinical data collection to four additional MMJ-legal U.S. states.

Tikun Olam and MariMed's relationship started in 2015 with a pilot program in Delaware. It marked the first time that U.S. patients had access to the world's only cannabis strains proven to deliver symptomatic relief for specific conditions including cancer, PTSD, epilepsy, Crohn's Disease/Colitis, chronic pain and neuropathy, among others.

MariMed, Inc. (MRMD), closed Tuesday's trading session at $0.53, up 6.00%, on 27,241 volume with 17 trades. The average volume for the last 60 days is 25,026 and the stock's 52-week low/high is $0.0553/$0.835.

ProtoKinetix, Inc. (PKTX)

Stock Rich, PennyStockAce, Stockpalooza, SuperBirdStocks, WallStAlerts, Willy Wizard, Pick Alerts, Penny stock Profitz, AllPennyStocks, Penny Invest, CoolPennyStocks, SmallCapVoice, TopPennyStockMovers, 777 Stocks, Breaking Bulls, InsideBulls, Stock Market News Alert, HotOTC, OTCReporter, StockEgg, and Round Up the Bulls reported on ProtoKinetix, Inc. (PKTX), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

ProtoKinetix, Inc. is a molecular biotechnology company based in St. Mary’s, West Virginia. It has developed and patented a family of hyper stable, potent glycopeptides (Anti-Aging GlycoPeptide - AAGP™) that enhance engraftment and protection of transplanted cells used in regenerative medicine. Because of the anti-inflammatory effect of AAGP™ molecules, ProtoKinetix is presently targeting the direct treatment of diseases that have a major inflammatory component. The Company’s molecule, AAGP™, is an antifreeze glycopeptide. It imitates a naturally occurring glycoprotein found in Arctic fish.

The Company’s AAGP™ molecule is helping to substantially improve the efficacy of Cell Transplant Treatments for diabetes. ProtoKinetix has wide-ranging patent protection for its portfolio of anti-aging glycopeptides. Its anti-aging glycopeptide, trademarked AAGP™, is a small (580.96 Daltons), stable, synthetic replica of the larger (>2,600 Daltons), less stable AFGP, which has been found to have protective properties in nature. 

The small size of AAGP™ enables it to penetrate cells and allows it to pass through cell and capillary junctions in vivo. Additionally, its bioactivity at a range of pHs (5.3-10.3) and temperatures (-196°C to 22°C) and efficiency at concentrations (1mg/ml) is well under its toxic dose (50mg/ml). This makes it a candidate to enter the next stages of translational research.

ProtoKinetix announced in March 2017 the start of a Phase 1 first-in-human clinical trial of AAGP™ PKX-001 treated islet cells used together with the Edmonton Protocol for the treatment of Type 1 diabetes. The first patient was treated under the protocol.

ProtoKinetix announced this past May that it completed the first year of retinal replacement therapy trials on animals. It said that the results are encouraging enough to proceed to a second phase of testing. The study conducted by the Gregory-Evans Retinal Therapeutic Lab at the University of British Columbia compared the results of transplanted retinal precursor cells with and without the addition of AAGP™.

The cells treated with AAGP™ showed an improvement on cell survivability and viability in comparison to the untreated cells. Continuing testing is now taking place to determine if these transplanted cells are fully functioning. 

ProtoKinetix and Proactive Immune Sciences recently announced that they entered into a joint research collaboration. The objective of the research will be to test the effect of the patented anti-aging glycopeptide AAGP™ on the immune cell cryopreservation protocols used by Proactive Immune Sciences.

ProtoKinetix, Inc. (PKTX), closed Tuesday's trading session at $0.0593, up 11.89%, on 121,004 volume with 11 trades. The average volume for the last 60 days is 87,072 and the stock's 52-week low/high is $0.0401/$0.189.

Sierra Monitor Corp. (SRMC)

Wall Street Resources, Stock News Now, Marketbeat, Zacks, MicroCap Gems, and SmallCapVoice reported previously on Sierra Monitor Corp. (SRMC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sierra Monitor Corp. is a provider of Industrial Internet of Things (IIoT) solutions that target facility automation and facility safety requirements. The Company’s FieldServer brand of protocol gateways is utilized by system integrators and original equipment manufacturers (OEMs) to enable local and remote monitoring and control of assets and facilities. FieldServer is the industry's foremost multi-protocol gateway, with more than 200,000 products, supporting greater than 140 protocols, installed in industrial and commercial facilities. Sierra Monitor is headquartered in Milpitas, California.

The Company’s industry-leading BACnet gateways, routers, and network explorers are now "IIoT-Empowered out-of-the-box". They are shipping with new software that permits customers to securely register, access, and also manage their field-installed products from the Company’s FieldPoP™ device cloud. 

In addition, Sierra Monitor’s Sentry IT fire and gas detection solutions are utilized by industrial and commercial facilities managers to protect their personnel and assets. Sentry IT branded controllers, sensor modules, and software are installed at thousands of facilities. These include natural gas vehicle fueling and maintenance stations, wastewater treatment plants, oil and gas refineries and pipelines, parking garages, U.S. Navy ships, and underground telephone vaults. 

Sierra Monitor announced earlier this year the availability of the BACnet Explorer NG, the industry’s first cloud-connected network discovery and management solution for BACnet networks. BACnet is an industry-standard protocol widely used in building and facility automation. 

The combination of the “plug-and-play” BACnet Explorer NG appliance and Sierra Monitor’s FieldPoP™ device cloud enables installers and system integrators to seamlessly and remotely discover and manage BACnet MS/TP and BACnet/IP devices on an automation network, test newly installed devices, debug the network, upload device and network information to the cloud, integrate device and network data with sophisticated cloud-based software applications, and provide a control path back to the network and devices.

Last month, Sierra Monitor announced its financial results for Q2 ended June 30, 2017. The Company reported Q2 2017 Net Sales of roughly $4.8 million, versus roughly $4.8 million in the same year ago period. It recorded Q2 2017 Gross Profit of 58 percent, versus 58 percent in the same year ago period. Sierra Monitor reported Q2 2017 GAAP Net Loss per Share of $0.04 (basic and diluted), versus GAAP Net Income of $0.00 per share (basic and diluted) for the year ago period.

Sierra Monitor Corp. (SRMC), closed Tuesday's trading session at $1.25, down 0.79%, on 5,500 volume with 2 trades. The average volume for the last 60 days is 5,670 and the stock's 52-week low/high is $1.18/$1.85.

graphic

The QualityStocks
Company Corner

graphic
graphic

LottoGopher Holdings Inc. (OTCQB:LTTGF) (CSE:LOTO) (FRA:2LG)

The QualityStocks Daily Newsletter would like to spotlight LottoGopher Holdings Inc. (LTTGF). Today, LottoGopher Holdings Inc. closed trading at $0.1889, up 24.77%, on 281,334 volume with 140 trades. The stock’s average daily volume over the past 60 days is 35,378 and its 52-week low/high is $0.15/$0.50.

Network News Wire, a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the online availability of its interview with LottoGopher Holdings Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRANKFURT: 2LG), a new lottery ticket messenger service that allows users to easily order and manage the purchase of state lottery tickets online using credit and debit cards. The interview can be heard at http://nnw.fm/lottogopher-interview-sept-2017 

LottoGopher Holdings Inc. (LTTGF) is a new lottery messenger service that provides its subscribers with the security of ordering and managing the legal purchase of state lottery tickets online using debit and credit cards. LottoGopher makes it simple for users to keep track of tickets and winnings. Members have exclusive access to strategies, alerts, lottery news and can play alone with a single ticket or join online public or private groups to pool winnings.

LottoGopher is transforming the lottery buying experience, which has historically meant taking the time and spending the gas money to drive to a retail location, then stand in line to buy via cash only and redeem tickets. LottoGopher's uniquely online messenger service streamlines the experience of taking a shot at the lottery and makes it much more convenient and access to electronic payment, otherwise not permitted in CA. While only California residents at this time can play Mega Millions, SuperLotto Plus and Powerball through LottoGopher.com, expansion plans are in the works to allow internet-savvy residents in 22 other states with legal lotteries to have the same advantages of purchasing tickets online.

LottoGopher also enjoys a strategic business relationship with Lottoland, ranked in the Financial Times' FT1000 Report as one of Britain's Top 30 fastest growing companies and as the second ranked gaming company in Europe. Since launching in 2013, Lottoland has rapidly become a world leader in the online lottery sector with nearly $357 million (U.S. dollars) in annual sales.

LottoGopher's currently integrated support systems include a mobile friendly platform; automated email follow-up system to capture, score and remarket to email address leads; social media listening and outreach; utilization of Google Analytics tools; one-time promotional offers across multiple platforms; main and backup credit card processing accounts; and focus on customer service.

Customers of LottoGopher pay a subscription fee to use the service, much like Netflix, Amazon Prime or Dollar Shave Club. After selecting their subscription plan, users pay the same price per ticket as if purchasing from a retail, brick-and-mortar location. LottoGopher's team then secures the selected tickets from a lottery retailer partner. User account balances are updated after a drawing, which makes it impossible for a member to "lose" a winning ticket.

The company's target market includes the 80 million U.S. consumers already buying lottery tickets who typically purchase products online. Offering a far more convenient way to play the lottery via an intuitive platform, LottoGopher is well positioned to disrupt this multi-billion dollar industry. Disclaimer

LottoGopher Holdings Inc. Blog

LottoGopher Holdings Inc. News:

NetworkNewsWire Releases Exclusive Audio Interview with LottoGopher Holdings Inc.

NetworkNewsWire Announces Publication on Successful Subscription Businesses

LottoGopher Holdings Inc. Announces William Shatner as the Company Spokesperson

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.345, up 4.55%, on 354,602 volume with 208 trades. The stock’s average daily volume over the past 60 days is 340,860, and its 52-week low/high is $0.073/$0.72.

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today that it has retained the consulting services of Ben Paterson, P.E., to assist in defining the pathway for the scale-up, purification, and manufacturing strategies for InMed's cannabinoid biosynthesis program. Ben Paterson is Principal Consultant at PatersonChemE Consulting, LLC.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Retains Consultant Ben Paterson for Biosynthesis Development

NetworkNewsWire Announces Publication Highlighting the Potential of Cannabinoid Biosynthesis

NetworkNewsWire Announces Publication Discussing Innovative Drug Developments in the Global Marijuana Market

Patriot One Technologies, Inc. (TSX.V:PAT) (OTCQB:PTOTF)

The QualityStocks Daily Newsletter would like to spotlight Patriot One Technologies, Inc. (PTOTF). Today, Patriot One Technologies, Inc. closed trading at $0.5519, up 1.30%, on 180,057 volume with 56 trades. The stock’s average daily volume over the past 60 days is 51,268, and its 52-week low/high is $0.4665/$1.49.

Patriot One Technologies Inc. (TSX VENTURE: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL), makers of the award-winning PATSCAN CMR™ (Cognitive Microwave Radar) concealed weapons detection system are pleased to announce that Company management will be presenting, exhibiting, and participating in a panel session at the Extraordinary Future Conference on September 20th in Vancouver.

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology.

Developed through a NATO-funded project at McMaster University, Patriot One's disruptive NForce CMR1000 technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.

A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world's population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren't taken.

Patriot One's patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a "cognitive" ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.

In contrast, Patriot One's technology is small in size and can be "covertly" placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.

The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.

The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.

Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols. Disclaimer

Patriot One Technologies, Inc. Company Blog

Patriot One Technologies, Inc. News:

Patriot One to Present at Extraordinary Future 2017 Investment Conference

Patriot One Completes FCC and IC Submission in Preparation for PATSCAN CMR Commercialization

NetworkNewsWire Releases Exclusive Audio Interview with Patriot One Technologies, Inc. (PTOTF)

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.0625, off by 1.57%, on 1,579,014 volume with 174 trades. The stock’s average daily volume over the past 60 days is 4,243,120, and its 52-week low/high is $0.002/$0.0995.

PotNetwork Holding, Inc. (OTC Pink: POTN) was pleased to announce today that the Company remains resolute, strong and open for business. Following what meteorologists considered the largest hurricane to hit Florida, Diamond CBD, fortunate to have averted any storm damage, has committed to strengthen community rebuilding efforts by generously donating 10% of all net proceeds originated from DiamondCBD.com, over the 3 day duration of its 50% off storewide Hurricane Irma Relief promotion.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Holding, Inc. Launches Storewide Discount on Diamond CBD Products to Support Recovery Efforts by Contributing 10% of Revenues over the Next 3 Days to Community Restoration Projects

PCAOB Registered CPA Firm Engaged to Initiate Audit on PotNetwork Holding, Inc.’s Recent Revenues

Mayweather vs. McGregor Event Brings Unprecedented Exposure to Diamond CBD and PotNetwork Holdings, “POTN”, as Sponsored Contenders Take the Spotlight

Greenkraft, Inc. (GKIT)

The QualityStocks Daily Newsletter would like to spotlight Greenkraft, Inc. (GKIT). Today, Greenkraft, Inc. closed trading at $0.1129, up 7.52%, on 5,299 volume with 2 trade. The stock’s average daily volume over the past 60 days is 11,992 and its 52-week low/high is $0.019/$0.20.

Greenkraft, Inc. (GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company's mission is to provide clean, green, energy efficient automotive products that have a price advantage coupled with unparalleled American performance. Established in 2008, Greenkraft, Inc. serves the commercial truck market powered by the alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

Greenkraft's new line of trucks, known as the G3 and G4, will accommodate weights of 26,000 lbs. and 33,000 lbs., respectively. George Gemayel, CEO of Greenkraft, Inc., said the demand for larger trucks that run on alternative fuels continues to increase.

"Greenkraft is going to revolutionize the trucking industry with these new 26,000 and 33,000 lbs. trucks that run on CNG and PROPANE fuel," Gemayel states in a press release. "The only way we can meet increased demand for Greenkraft products is to expand our current factory. This expansion is one of many factors that will substantially increase the Company's revenue in 2017."

Greenkraft produces a cab forward design for its commercial trucks, which allows the passenger area to be much larger than in other similar sized vehicles. Several tank capacity options exist, making it easy to select the most efficient model for a client's specific needs. Greenkraft is one of the only companies in the world to offer a refrigeration option with an alternative fuel truck – an essential, must-have option for many businesses.

Greenkraft trucks, considered among the best performing in the heavy-duty market, are used in a variety of industries and in some of the nation's largest cities. The company also offers a line of trucks designed to run with a package from Allison Transmission Holdings, Inc. (NYSE: ALSN), which gives clients the option of purchasing a fully automatic transmission vehicle. This option expands the size of the driver pool since fully automatic shifting reduces driver fatigue, contributes to solving the issue of driver retention, and it is easy to use.

CNG and LPG conversion systems made by Greenkraft are available for several major automobile brands including Ford, GM and Isuzu/GM. Installation, service, parts and warranty are all available through Greenkraft facilities and its partners. Disclaimer

Greenkraft, Inc. Blog

Greenkraft, Inc. News:

Greenkraft, Inc. (GKIT) Making Itself Available to the Entirety of the United States

Greenkraft, Inc. (OTCQB: GKIT) Now Offering an Allison Transmission for Their Alternative Fuel Trucks

Greenkraft, Inc. Publishes 500% Revenue Increase and Continues Positive Momentum by Achieving Near Zero Emissions in Their Trucks

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

MarketBeat
(FWDG) +100.00%

2.

Trader Power News
(CAPR) +70.45%

3.

MarketClub Analysis
(HMNY) +63.79%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251